Alessia Pacifico Selected Research

Alessia Pacifico Research Topics

Disease

16	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023 - 04/2005
4	Vitiligo 11/2022 - 10/2011
3	Erythema 10/2023 - 08/2021
3	Skin Diseases (Skin Disease) 01/2021 - 04/2005
2	Contact Dermatitis (Eczema, Contact) 04/2021 - 01/2006
2	COVID-19 01/2021 - 07/2020
2	Psoriatic Arthritis 10/2020 - 03/2019
1	Acrodermatitis (Gianotti Crosti Syndrome) 12/2023
1	Benign Migratory Glossitis (Geographic Tongue) 10/2023
1	Leukoplakia 10/2023
1	Aphthous Stomatitis (Aphthous Ulcer) 10/2023
1	Stomatitis 10/2023
1	Hidradenitis Suppurativa 10/2023
1	Papilloma (Papillomatosis) 10/2023
1	Oral Manifestations 10/2023
1	Sleepiness 05/2022
1	Pruritus (Itching) 05/2022
1	Mycosis Fungoides 07/2021
1	Facial Dermatoses 04/2021
1	Ageusia (Hypogeusia) 01/2021
1	Anosmia 01/2021
1	Arthritis (Polyarthritis) 10/2020
1	Asthma (Bronchial Asthma) 10/2020
1	Inflammation (Inflammations) 10/2020
1	Substance-Related Disorders (Drug Abuse) 05/2019
1	Ankylosing Spondylitis 03/2019
1	Acute Generalized Exanthematous Pustulosis 01/2019
1	Chronic Hepatitis C 02/2018
1	Histiocytosis 11/2017
1	Neoplasms (Cancer) 11/2003

Drug/Important Bio-Agent (IBA)

4	risankizumabIBA 12/2023 - 09/2023
3	Interleukin-17 (Interleukin 17)IBA 10/2023 - 01/2019
2	ixekizumabIBA 12/2023 - 01/2019
2	Interleukin-23 (Interleukin 23)IBA 10/2023 - 09/2023
2	secukinumabIBA 01/2022 - 05/2019
2	Irritants (Vesicants)IBA 04/2021 - 01/2006
2	Antiviral Agents (Antivirals)IBA 01/2021 - 02/2018
2	Interleukin-12 (IL 12)IBA 01/2019 - 01/2019
1	Monoclonal AntibodiesIBA 09/2023
1	Glucose (Dextrose)FDA LinkGeneric 11/2022
1	Adenosine Triphosphate (ATP)IBA 11/2022
1	Pioglitazone (Actos)FDA Link 11/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2022
1	LipidsIBA 09/2022
1	Histamine Antagonists (Antihistamines)IBA 05/2022
1	rupatadineIBA 05/2022
1	Aprepitant (Emend)FDA Link 05/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022
1	apremilastIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Interleukin-1 (Interleukin 1)IBA 08/2021
1	Interleukin-6 (Interleukin 6)IBA 08/2021
1	CytokinesIBA 08/2021
1	tetraiodothyroacetic acid (TA(4))IBA 01/2021
1	TetracyclinesIBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2020
1	S 10 (S-10)IBA 10/2020
1	Acitretin FDA Link 01/2020
1	Biomarkers (Surrogate Marker)IBA 11/2019
1	C-Reactive ProteinIBA 03/2019
1	Dabigatran FDA Link 01/2019
1	Ribavirin (Virazole)FDA LinkGeneric 02/2018
1	xenon chlorideIBA 10/2011
1	Melanins (Melanin)IBA 10/2011
1	tazarotene (Tazorac)FDA Link 01/2006
1	Cholecalciferol (Vitamin D3)FDA Link 04/2005
1	1 alpha,24-dihydroxyvitamin D3 (Tacalcitol)IBA 04/2005
1	Ointments (Pastes)IBA 04/2005
1	Anthralin (Dithranol)IBA 04/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2005
1	DNA (Deoxyribonucleic Acid)IBA 11/2003

Therapy/Procedure

8	Therapeutics 10/2023 - 01/2006
7	Phototherapy (Light Therapy) 12/2023 - 10/2011
2	Biological Therapy 09/2023 - 07/2020
1	Tattooing 10/2023
1	Ultraviolet Therapy (Therapy, Ultraviolet) 06/2022
1	Photochemotherapy (Photodynamic Therapy) 06/2022
1	Contraindications 01/2022
1	Excimer Lasers 10/2011
1	Aftercare (After-Treatment) 04/2005